Biotech · Private company
Immune Response BioPharma, Inc.
Track this companyFree. Adds Immune Response BioPharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- NeuroVaxPhase 3 · Secondary Progress Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- IFA Incomplete Freund's AdjuvantPhase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- NeuroVaxPhase 2 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple SclerosisPHASE1 · UNKNOWN · started Dec 31, 2020ClinicalTrials.gov NCT02200718 · fetched Nov 12, 2026
- A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple SclerosisPHASE2_PHASE3 · UNKNOWN · started Mar 9, 2020ClinicalTrials.gov NCT02057159 · fetched Nov 12, 2026
- A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple SclerosisPHASE2 · UNKNOWN · started Mar 9, 2020ClinicalTrials.gov NCT02149706 · fetched Nov 12, 2026